Trial · NCT07882979
Applying Comfort Theory to an AI-Assisted Group Music Intervention: Psychosocial and Physiological Outcomes and Feasibility in Long-Term Care Residents.
NCT07882979, Not applicable, Not yet recruiting, Yu Chia Chang
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Applying Comfort Theory to an AI-Assisted Group Music Intervention: Psychosocial and Physiological Outcomes and Feasibility in Long-Term Care Residents. Trials, record NCT07882979. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882979
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Applying Comfort Theory to an AI-Assisted Group Music Intervention: Psychosocial and Physiological Outcomes and Feasibility in Long-Term Care Residents.
- NCT number
- NCT07882979
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Yu Chia Chang
- Conditions
- Comfort Theory, AI-Assisted Group Music Intervention, Long-Term Care Residents, Loneliness, Anxiety, Depression
- Interventions
- Group music intervention, AI-assisted monitoring system
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | UCLA Loneliness Scale, Version 3 | T0 (pre-intervention): before the first group music session (week 1); T1 (post-intervention): after completion of the sixth group music session (week 6) | A 20-item self-report scale rated on a 4-point Likert scale (1 = never to 4 = always). Total scores range from 20 to 80, with higher scores indicating greater loneliness. The score ranges are defined as follows: 20-34 points for low loneliness, 35-49 points for moderate loneliness, 50-64 points for high loneliness, and 65-80 points for severe loneliness. |
| Primary | Chinese version of Beck Anxiety Inventory | T0 (pre-intervention): before the first group music session (week 1); T1 (post-intervention): after completion of the sixth group music session (week 6) Measured in Stage 1 and 2 participants | A 21-item scale with each item scored from 0 (not at all) to 3 (severely). Total scores range from 0 to 63, with higher scores indicating more severe anxiety. |
| Primary | Geriatric Depression Scale-15 | T0 (pre-intervention): before the first group music session (week 1); T1 (post-intervention): after completion of the sixth group music session (week 6) Measured in Stage 1 and 2 participants | A 15-item yes/no scale. Total scores range from 0 to 15, with higher scores indicating more depressive symptoms. Administered with the help of trained research staff. |
| Secondary | Heart Rate Variability | T0 (pre-intervention): before the first group music session (week 1); T1 (post-intervention): after completion of the sixth group music session (week 6) Measured in Stage 2 participants only. | Resting HRV is recorded with an eSense HRV recorder (500 Hz sampling rate) during a 5-minute seated recording after 5 minutes of seated rest, under similar posture, time of day, and environment at both time points. Time-domain parameters (SDNN and RMSSD, ms) and frequency-domain parameters (LF and HF power, ms², and LF/HF ratio) are calculated from RR intervals. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882979
GET https://conductscience.org/api/trials/v1/NCT07882979/registered